Citius Oncology to Advance Commercial Launch of LYMPHIR™ with Verix AI Integration
Provided By PR Newswire
Last update: Nov 21, 2025
Leading edge artificial intelligence and machine learning platform supports enhanced salesforce targeting and engagement for cutaneous T-cell lymphoma immunotherapy launch
Read more at prnewswire.com1.26
+0.05 (+4.13%)
1.4
+0.18 (+14.75%)
Find more stocks in the Stock Screener
